Cite
EFFECTS OF OMALIZUMAB ON MARKERS OF TYPE 2 INFLAMMATION: RESULTS FROM THE EXTRA STUDY.
MLA
Chipps, B., et al. “Effects of Omalizumab on Markers of Type 2 Inflammation: Results from the Extra Study.” Annals of Allergy, Asthma & Immunology, vol. 121, Nov. 2018, pp. S5–6. EBSCOhost, https://doi.org/10.1016/j.anai.2018.09.015.
APA
Chipps, B., Casale, T., Yang, M., Holweg, C., Haselkorn, T., Griffin, N., & Hanania, N. (2018). Effects of Omalizumab on Markers of Type 2 Inflammation: Results from the Extra Study. Annals of Allergy, Asthma & Immunology, 121, S5–S6. https://doi.org/10.1016/j.anai.2018.09.015
Chicago
Chipps, B., T. Casale, M. Yang, C. Holweg, T. Haselkorn, N. Griffin, and N. Hanania. 2018. “Effects of Omalizumab on Markers of Type 2 Inflammation: Results from the Extra Study.” Annals of Allergy, Asthma & Immunology 121 (November): S5–6. doi:10.1016/j.anai.2018.09.015.